Stock Movers: Pfizer Gains, CoreWeave Climbs on Meta Deal, Firefly Aerospace Plunges

Pfizer's Stock Surge

• 📈 Pfizer (PFE) is the second-biggest gainer in the S&P 500, with shares rising approximately 6.5%, marking its largest intraday gain since May 2024.
• 🤝 This surge is linked to a reported agreement where Pfizer will voluntarily sell its medications through Medicaid at lower prices, potentially receiving a three-year reprieve from pharma tariffs.
• 💰 The company plans to offer a 50% discount on some drugs through a direct-to-consumer website, aiming to compensate for the price cut through increased volume.
• 🌟 Peers like Eli Lilly and Merck also saw significant gains, indicating broad positivity within the pharmaceutical industry.

CoreWeave's AI-Driven Deal with Meta

• 🚀 CoreWeave (CRWV) shares climbed as much as 16% following a significant deal with Meta Platforms.
• 💡 The cloud-computing provider will supply Meta with up to $14.2 billion worth of computing power through December 2031, with an option to extend through 2032.
• 🌐 This agreement highlights the immense demand for artificial intelligence infrastructure and helps CoreWeave diversify its business beyond Microsoft.
• 📊 CoreWeave has experienced a fantastic year, with its stock up over 242% year-to-date.

Firefly Aerospace's Rocket Explosion

• 💥 Firefly Aerospace (FLY) experienced a sharp decline, plunging as much as 25% after a core segment of one of its rockets exploded during a test.
• 📉 The incident resulted in the complete loss of the Alpha Flight 7 first stage, making the company's plans to launch two Alpha rockets by year-end unlikely.
• ⚠️ This marks the second mishap for Firefly Aerospace, following the loss of its Flight 6 rocket in April, and shares are down for their worst day on record.
• 🧑‍🚀 All personnel were reported safe, but the loss of the rocket stage significantly impacts the company's launch schedule.